{"transactions":[{"id":706106,"issuer":{"id":29609,"kind":"organization","name":"Inotiv, Inc.","symbol":"NOTVQ"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-20T20:27:59.000Z","date":"2026-07-19","kind":"other","planned":false,"acquired":false,"shares":74303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Amended Joint Prepackaged Chapter 11 Plan of Reorganization of Inotiv, Inc. and its Affiliated Debtors (the \"Plan\") under Chapter 11 of the Bankruptcy Code was confirmed by the United States Bankruptcy Court for the Southern District of Texas, Houston Division, on July 14, 2026, and became effective on July 19, 2026. On the effective date of the Plan, all outstanding common shares and other equity interests of Inotiv, Inc. were canceled for no consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001720772-26-000002","document":"form4-07202026_080756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/720154/000172077226000002/form4-07202026_080756.xml","form_type":"4"}},{"id":1082638,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-23T22:07:41.000Z","date":"2025-07-22","kind":"sale","planned":false,"acquired":false,"shares":13609,"price":0.92,"value":12520.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was affected pursuant to a \"sell to cover\" arrangement adopted by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units granted on July 22, 2024 and does not represent a discretionary trade by the Reporting Person.  Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":56266,"source":{"system":"sec-edgar","filing":"0001415889-25-020198","document":"form4-07232025_100733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720772/000141588925020198/form4-07232025_100733.xml","form_type":"4"}},{"id":1185468,"issuer":{"id":29609,"kind":"organization","name":"Inotiv, Inc.","symbol":"NOTVQ"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:32:56.000Z","date":"2025-04-01","kind":"sale","planned":false,"acquired":false,"shares":5500,"price":2.3483,"value":12915.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover taxes associated with the restricted stock units that vested on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,500 shares of common stock of Inotiv, Inc. sold by the reporting person in multiple transactions on April 1, 2025 with sales prices ranging from $2.175 to $2.42 per share.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":74303,"source":{"system":"sec-edgar","filing":"0001062993-25-006842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/720154/000106299325006842/form4.xml","form_type":"4"}},{"id":1202539,"issuer":{"id":29609,"kind":"organization","name":"Inotiv, Inc.","symbol":"NOTVQ"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T20:09:29.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":39392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in full on March 14, 2026, or immediately prior to the next annual meeting of stockholders if stepping down from the  Board."}],"balance_after":79803,"source":{"system":"sec-edgar","filing":"0001062993-25-005700","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/720154/000106299325005700/form4.xml","form_type":"4"}},{"id":1434314,"issuer":{"id":29609,"kind":"organization","name":"Inotiv, Inc.","symbol":"NOTVQ"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-15T01:34:07.000Z","date":"2024-08-10","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in full on March 31, 2025, provided that the grantee continues to serve as a director of the Company through the vesting date."}],"balance_after":40411,"source":{"system":"sec-edgar","filing":"0001062993-24-015126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/720154/000106299324015126/form4.xml","form_type":"4"}},{"id":1449186,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-07-24T20:18:15.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":69875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSU shall vest in two equal installments on July 22, 2025 and July 22, 2026, subject to the Reporting Person's continuous service through each such date."}],"balance_after":69875,"source":{"system":"sec-edgar","filing":"0001415889-24-020043","document":"form4-07242024_080711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720772/000141588924020043/form4-07242024_080711.xml","form_type":"4"}},{"id":1474423,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T20:15:18.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award shall vest and become fully exercisable on the earlier to occur of (a) June 17, 2025 and (b) the date of the Issuer's next annual meeting of its stockholders."}],"balance_after":49000,"derivative":{"exercise_price":0.71,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001415889-24-017388","document":"form4-06182024_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720772/000141588924017388/form4-06182024_040611.xml","form_type":"4"}},{"id":1687737,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T22:13:33.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":19633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2024, the Reporting Person was granted 19,633 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning April 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":20237,"source":{"system":"sec-edgar","filing":"0001104659-24-001438","document":"tm242126-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924001438/tm242126-1_4seq1.xml","form_type":"4"}},{"id":1758660,"issuer":{"id":29609,"kind":"organization","name":"Inotiv, Inc.","symbol":"NOTVQ"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T20:16:59.000Z","date":"2023-10-17","kind":"grant","planned":false,"acquired":true,"shares":12911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vests on April 1, 2024, provided that the grantee continues to serve as a director of the Company through such date."}],"balance_after":12911,"source":{"system":"sec-edgar","filing":"0001062993-23-019536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/720154/000106299323019536/form4.xml","form_type":"4"}},{"id":1855494,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-06-14T16:21:24.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on the earlier of (i) the date of the closing of a Merger/Sale (as such term is defined under the Issuer's 2017 Share Incentive Plan (as amended)), or (ii) May 22, 2024, so long as, prior to such date, (x) the Reporting Person has not terminated without cause the Reporting Person's Consulting Agreement (the \"Agreement\") with the Issuer or (y) the Issuer has not terminated the Agreement for breach (and such breach has not been cured)."}],"balance_after":10000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-06-11","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-037015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919123037015/doc4.xml","form_type":"4"}},{"id":1859984,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T21:13:07.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option shall vest on June 9, 2024, with the remainder vesting in 8 equal quarterly installments thereafter."}],"balance_after":52000,"derivative":{"exercise_price":1.01,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001104659-23-069996","document":"tm2318326-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720772/000110465923069996/tm2318326-1_4seq1.xml","form_type":"4"}},{"id":2062606,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T14:02:44.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":84745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 3, 2023, the Reporting Person was granted 84,745 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":84745,"source":{"system":"sec-edgar","filing":"0001104659-23-001231","document":"tm231522-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923001231/tm231522-7_4seq1.xml","form_type":"4"}},{"id":2435627,"issuer":{"id":116342,"kind":"organization","name":"CinCor Pharma, Inc.","symbol":"CINC"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP CFO & Chief BD Officer"}}],"security":"Common Stock","published_at":"2022-01-13T21:24:57.000Z","date":"2022-01-11","kind":"purchase","acquired":true,"shares":100,"price":16,"value":1600.0,"ownership":{"direct":false,"nature":"By child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by the Reporting Person's child. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her proportionate pecuniary interest therein."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-22-003184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720772/000120919122003184/doc4.xml","form_type":"4"}},{"id":2454292,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2022-01-04T02:07:30.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":34482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal quarterly installments on each of March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":34482,"derivative":{"exercise_price":1.45,"expiration_date":"2032-01-03","underlying":"Common stock, par value $0.0001 per share","underlying_shares":34482},"source":{"system":"sec-edgar","filing":"0001140361-22-000303","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122000303/form4.xml","form_type":"4"}},{"id":2571961,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-09-14T00:08:11.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":10310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of derivative securities reported has not been adjusted to reflect the 10-for-1 reverse stock split of AzurRx BioPharma, Inc. common stock that occurred on September 13, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests on December 31, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of derivative securities reported has not been adjusted to reflect the 10-for-1 reverse stock split of AzurRx BioPharma, Inc. common stock that occurred on September 13, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of derivative securities reported has not been adjusted to reflect the 10-for-1 reverse stock split of AzurRx BioPharma, Inc. common stock that occurred on September 13, 2021."}],"balance_after":10310,"derivative":{"exercise_price":0.64,"expiration_date":"2031-09-09","underlying":"Common stock, par value $0.0001 per share","underlying_shares":10310},"source":{"system":"sec-edgar","filing":"0001415889-21-004371","document":"form4-09132021_050904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588921004371/form4-09132021_050904.xml","form_type":"4"}},{"id":2886390,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-02-02T19:12:22.000Z","date":"2021-01-29","kind":"exercise","acquired":false,"shares":10190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 10,190 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on January 29, 2020 under the Issuer's 2019 Stock Option Incentive Plan, as amended. The remainder of the RSUs under this grant will vest in equal portions on January 29, 2022 and January 29, 2023."}],"balance_after":20381,"derivative":{"exercise_price":0,"expiration_date":"2023-01-29","underlying":"Common Stock","underlying_shares":10190},"source":{"system":"sec-edgar","filing":"0001103021-21-000018","document":"wf-form4_161231111864978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000018/wf-form4_161231111864978.xml","form_type":"4"}},{"id":2886389,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-02T19:12:22.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":3460,"price":3.87,"value":13390.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 1, 2021, the Reporting Person sold an aggregate of 3,460 shares of the Issuer's Common Stock at a weighted average price of $3.87 per share. The highest sale price for the Common Stock was $3.89 per share and the lowest sale price was $3.87 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":30619,"source":{"system":"sec-edgar","filing":"0001103021-21-000018","document":"wf-form4_161231111864978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000018/wf-form4_161231111864978.xml","form_type":"4"}},{"id":2886388,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-02T19:12:22.000Z","date":"2021-01-29","kind":"exercise","acquired":true,"shares":10190,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34079,"source":{"system":"sec-edgar","filing":"0001103021-21-000018","document":"wf-form4_161231111864978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000018/wf-form4_161231111864978.xml","form_type":"4"}},{"id":2890666,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-01-29T19:06:57.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2021, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2022; (ii) January 27, 2023; and (iii) January 27, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock."}],"balance_after":62500,"derivative":{"exercise_price":0,"expiration_date":"2024-01-27","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001103021-21-000008","document":"wf-form4_161196520326361.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000008/wf-form4_161196520326361.xml","form_type":"4"}},{"id":2890665,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (right to buy)","published_at":"2021-01-29T19:06:57.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":344632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2021."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The stock options were issued to the Reporting Person on January 27, 2021, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2022; (ii) January 27, 2023; and (iii) January 27, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on January 27, 2021, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2022; (ii) January 27, 2023; and (iii) January 27, 2024."}],"balance_after":344632,"derivative":{"exercise_price":3.84,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":344632},"source":{"system":"sec-edgar","filing":"0001103021-21-000008","document":"wf-form4_161196520326361.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000008/wf-form4_161196520326361.xml","form_type":"4"}},{"id":2902691,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-01-20T16:30:26.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 18,333 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant vest on January 15, 2022."}],"balance_after":18334,"derivative":{"exercise_price":0,"exercise_date":"2020-01-15","expiration_date":"2022-01-17","underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001103021-21-000002","document":"wf-form4_161117821292460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000002/wf-form4_161117821292460.xml","form_type":"4"}},{"id":2902690,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-20T16:30:26.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":6462,"price":4.32,"value":27915.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Reporting Person sold an aggregate of 6,462 shares of the Issuer's Common Stock at a weighted average price of $4.32 per share. The highest sale price for the Common Stock was $4.34 per share and the lowest sale price was $4.32 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":23889,"source":{"system":"sec-edgar","filing":"0001103021-21-000002","document":"wf-form4_161117821292460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000002/wf-form4_161117821292460.xml","form_type":"4"}},{"id":2902689,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-20T16:30:26.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30351,"source":{"system":"sec-edgar","filing":"0001103021-21-000002","document":"wf-form4_161117821292460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000002/wf-form4_161117821292460.xml","form_type":"4"}},{"id":3296879,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-01-31T17:46:23.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":30571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 29, 2020, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 29, 2021; (ii) January 29, 2022; and (iii) January 29, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock."}],"balance_after":30571,"derivative":{"exercise_price":0,"expiration_date":"2023-01-29","underlying":"Common Stock","underlying_shares":30571},"source":{"system":"sec-edgar","filing":"0001103021-20-000019","document":"wf-form4_158051076576609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000019/wf-form4_158051076576609.xml","form_type":"4"}},{"id":3296878,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (right to buy)","published_at":"2020-01-31T17:46:23.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":148665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Issuer's common stock for the 30-day period ending on January 28, 2020."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The stock options were issued to the Reporting Person on January 29, 2020, pursuant to a grant under the Issuer's 2019 Stock Option and Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 29, 2021; (ii) January 29, 2022; and (iii) January 29, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on January 29, 2020, pursuant to a grant under the Issuer's 2019 Stock Option and Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 29, 2021; (ii) January 29, 2022; and (iii) January 29, 2023."}],"balance_after":148665,"derivative":{"exercise_price":6.17,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":148665},"source":{"system":"sec-edgar","filing":"0001103021-20-000019","document":"wf-form4_158051076576609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000019/wf-form4_158051076576609.xml","form_type":"4"}},{"id":3308268,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (right to buy)","published_at":"2020-01-17T16:06:29.000Z","date":"2020-01-15","kind":"exercise","acquired":false,"shares":35703,"price":3.73,"value":133172.19,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the exercise of stock options granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the stock options under this grant vest in equal portions on: (i) January 15, 2021; and (ii) January 15, 2022."}],"balance_after":71406,"derivative":{"exercise_price":3.73,"exercise_date":"2020-01-15","expiration_date":"2029-01-17","underlying":"Common Stock","underlying_shares":35703},"source":{"system":"sec-edgar","filing":"0001103021-20-000010","document":"wf-form4_157929516784215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000010/wf-form4_157929516784215.xml","form_type":"4"}},{"id":3308267,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-01-17T16:06:29.000Z","date":"2020-01-15","kind":"exercise","acquired":false,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 18,333 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant vest in equal portions on: (i) January 15, 2021; and (ii) January 15, 2022."}],"balance_after":36667,"derivative":{"exercise_price":0,"exercise_date":"2020-01-15","expiration_date":"2022-01-17","underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001103021-20-000010","document":"wf-form4_157929516784215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000010/wf-form4_157929516784215.xml","form_type":"4"}},{"id":3308266,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-17T16:06:29.000Z","date":"2020-01-16","kind":"sale","acquired":false,"shares":42018,"price":5.98,"value":251267.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 16, 2020, the Reporting Person sold an aggregate of 42,018 shares of the Issuer's Common Stock at a weighted average price of $5.98 per share. The highest sale price for the Common Stock was $6.00 per share and the lowest sale price was $5.89 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":12018,"source":{"system":"sec-edgar","filing":"0001103021-20-000010","document":"wf-form4_157929516784215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000010/wf-form4_157929516784215.xml","form_type":"4"}},{"id":3308265,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-17T16:06:29.000Z","date":"2020-01-15","kind":"exercise","acquired":true,"shares":35703,"price":3.73,"value":133172.19,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":54036,"source":{"system":"sec-edgar","filing":"0001103021-20-000010","document":"wf-form4_157929516784215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000010/wf-form4_157929516784215.xml","form_type":"4"}},{"id":3308264,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-01-17T16:06:29.000Z","date":"2020-01-15","kind":"exercise","acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":18333,"source":{"system":"sec-edgar","filing":"0001103021-20-000010","document":"wf-form4_157929516784215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000010/wf-form4_157929516784215.xml","form_type":"4"}},{"id":3691972,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (right to buy)","published_at":"2019-01-18T18:05:55.000Z","date":"2019-01-17","kind":"grant","acquired":true,"shares":107109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Company's common stock for the 30-day period ending on January 16, 2019."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The stock options were issued to the Reporting Person on January 17, 2019, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 15, 2020; (ii) January 15, 2021; and (iii) January 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options were issued to the Reporting Person on January 17, 2019, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 15, 2020; (ii) January 15, 2021; and (iii) January 15, 2022."}],"balance_after":107109,"derivative":{"exercise_price":3.73,"expiration_date":"2029-01-17","underlying":"Common Stock","underlying_shares":107109},"source":{"system":"sec-edgar","filing":"0000899243-19-001537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319001537/doc4.xml","form_type":"4"}},{"id":3691971,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-01-18T18:05:55.000Z","date":"2019-01-17","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 17, 2019, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 15, 2020; (ii) January 15, 2021; and (iii) January 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A."}],"balance_after":55000,"derivative":{"exercise_price":0,"expiration_date":"2022-01-17","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000899243-19-001537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319001537/doc4.xml","form_type":"4"}},{"id":3781067,"issuer":{"id":3839,"kind":"organization","name":"BALCHEM CORP","symbol":"BALCHEM CO"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-30T14:00:13.000Z","date":"2018-10-26","kind":"grant","acquired":true,"shares":1132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 15, 2018, the reporting person was granted an option to purchase 5,030 shares of common stock scheduled to vest in installments of 20%, 40%, and 40% per year over the three-year period. The option reported herein as acquired resulted from the acceleration of vesting of 22.5% of such option in connection with a SA&GR."}],"balance_after":3337,"derivative":{"exercise_price":74.57,"exercise_date":"2018-10-26","expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":1132},"source":{"system":"sec-edgar","filing":"0001140361-18-041597","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9326/000114036118041597/form4.xml","form_type":"4"}},{"id":3781066,"issuer":{"id":3839,"kind":"organization","name":"BALCHEM CORP","symbol":"BALCHEM CO"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-30T14:00:13.000Z","date":"2018-10-29","kind":"tax_withholding","acquired":false,"shares":1187,"price":96.42,"value":114450.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Company granted 5,605 restricted shares under the Company's Long-Term Incentive Program. The shares were subject to certain restrictions under the applicable Restricted Stock Grant Agreements. 1,187 of the 3,210 shares that vested October 26, 2018 were withheld to cover withholding taxes due upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In connection with a Separation Agreement and General Release (SA&GR) between the Company and the reporting person, 1,050 shares previously reported as beneficially owned in connection with Restricted Stock Grant Agreements were forfeited."}],"balance_after":2105,"source":{"system":"sec-edgar","filing":"0001140361-18-041597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9326/000114036118041597/form4.xml","form_type":"4"}},{"id":4051049,"issuer":{"id":3839,"kind":"organization","name":"BALCHEM CORP","symbol":"BALCHEM CO"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-02-20T22:54:57.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":5030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest 20% year 1; 40% year 2; and 40% year 3."}],"balance_after":5030,"derivative":{"exercise_price":74.57,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":5030},"source":{"system":"sec-edgar","filing":"0001140361-18-009151","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9326/000114036118009151/form4.xml","form_type":"4"}},{"id":4051048,"issuer":{"id":3839,"kind":"organization","name":"BALCHEM CORP","symbol":"BALCHEM CO"},"owners":[{"id":29613,"kind":"person","name":"Coelho Mary Theresa","position":1,"cik":"0001720772","reported_name":"Coelho Mary Theresa","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-20T22:54:57.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":1260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person."}],"balance_after":4294,"source":{"system":"sec-edgar","filing":"0001140361-18-009151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9326/000114036118009151/form4.xml","form_type":"4"}}]}